4
Changes in Ownership
Taysha Gene Therapies, Inc. Filed Acc 0001209191-23-001020
Options or other derivatives
- Chief Executive Officer acquired 1,106,131 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Nolan Sean P. Chief Executive Officer | 2022-12-30 | Grant or award · Stock Option (right to buy) | +1,106,131 | 1,106,131 | D | ||
Loading xslF345X03/doc4.xml…